| EASL Clinical Practice Guidelines: management of hepatitis C virus infection European Association For The Study Of The Liver Journal of hepatology 55 (2), 245-264, 2011 | 2500 | 2011 |
| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017 | 2107 | 2017 |
| EASL recommendations on treatment of hepatitis C 2018 European Association for The Study of The Liver Journal of hepatology 69 (2), 461-511, 2018 | 1918* | 2018 |
| Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis AJ Van Der Meer, BJ Veldt, JJ Feld, H Wedemeyer, JF Dufour, F Lammert, ... Jama 308 (24), 2584-2593, 2012 | 1877 | 2012 |
| ABT-450/r–ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis F Poordad, C Hezode, R Trinh, KV Kowdley, S Zeuzem, K Agarwal, ... New England Journal of Medicine 370 (21), 1973-1982, 2014 | 1185 | 2014 |
| Treatment of acute hepatitis C with interferon alfa-2b E Jaeckel, M Cornberg, H Wedemeyer, T Santantonio, J Mayer, M Zankel, ... New England Journal of Medicine 345 (20), 1452-1457, 2001 | 1169 | 2001 |
| Treating viral hepatitis C: efficacy, side effects, and complications MP Manns, H Wedemeyer, M Cornberg Gut 55 (9), 1350-1359, 2006 | 932 | 2006 |
| Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma LA Ormandy, T Hillemann, H Wedemeyer, MP Manns, TF Greten, ... Cancer research 65 (6), 2457-2464, 2005 | 905 | 2005 |
| Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis BJ Veldt, EJ Heathcote, H Wedemeyer, J Reichen, WP Hofmann, ... Annals of internal medicine 147 (10), 677-684, 2007 | 869 | 2007 |
| Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection H Wedemeyer, XS He, M Nascimbeni, AR Davis, HB Greenberg, ... The Journal of Immunology 169 (6), 3447-3458, 2002 | 825 | 2002 |
| Retreatment of HCV with ABT-450/r–ombitasvir and dasabuvir with ribavirin S Zeuzem, IM Jacobson, T Baykal, RT Marinho, F Poordad, M Bourlière, ... New England Journal of Medicine 370 (17), 1604-1614, 2014 | 778 | 2014 |
| Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma AG Duffy, SV Ulahannan, O Makorova-Rusher, O Rahma, H Wedemeyer, ... Journal of hepatology 66 (3), 545-551, 2017 | 772 | 2017 |
| EASL recommendations on treatment of hepatitis C: final update of the series☆ JM Pawlotsky, F Negro, A Aghemo, M Berenguer, O Dalgard, G Dusheiko, ... Journal of hepatology 73 (5), 1170-1218, 2020 | 739 | 2020 |
| Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor B Hoechst, T Voigtlaender, L Ormandy, J Gamrekelashvili, F Zhao, ... Hepatology 50 (3), 799-807, 2009 | 703 | 2009 |
| Hepatitis delta virus SA Hughes, H Wedemeyer, PM Harrison The Lancet 378 (9785), 73-85, 2011 | 679 | 2011 |
| Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective J Jaroszewicz, BC Serrano, K Wursthorn, K Deterding, J Schlue, ... Journal of hepatology 52 (4), 514-522, 2010 | 602 | 2010 |
| The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ... Journal of viral hepatitis 21, 34-59, 2014 | 560 | 2014 |
| Peginterferon plus adefovir versus either drug alone for hepatitis delta H Wedemeyer, C Yurdaydìn, GN Dalekos, A Erhardt, Y Çakaloğlu, ... New England Journal of Medicine 364 (4), 322-331, 2011 | 545 | 2011 |
| Quantitative analysis of hepatitis C virus-specific CD8+ T cells in peripheral blood and liver using peptide-MHC tetramers XS He, B Rehermann, FX López-Labrador, J Boisvert, R Cheung, ... Proceedings of the National Academy of Sciences 96 (10), 5692-5697, 1999 | 522 | 1999 |
| Hepatitis E virus infection N Kamar, J Izopet, N Pavio, R Aggarwal, A Labrique, H Wedemeyer, ... Nature Reviews Disease Primers 3 (1), 1-16, 2017 | 518 | 2017 |
Markus CornbergProfessor of Medicine, Medizinische Hochschule Hannover在 mh-hannover.de 的电子邮件经过验证
